Skip to content
Trial Eligibility
Menu

A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors

NCT06411561

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Up to 25% of intensive care unit (ICU) survivors experience cognitive impairment comparable in severity to mild Alzheimer's disease and related dementias after hospital discharge. Older ICU survivors (ages 60 and older) are at highest risk for delirium and subsequent cognitive impairment, which contribute to higher risk for cognitive decline related to Alzheimer's disease and related dementias. Sleep and activity are essential for recovery from critical illness, yet ICU survivors experience both sleep deficiency and profound inactivity.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Critical Illness
  • Delirium
  • Cognitive Impairment
  • Cognitive Decline
  • Alzheimer's Disease
  • Dementia
  • Circadian Dysrhythmia
  • Sleep Disturbance

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
60 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Washington
Last updated on ClinicalTrials.gov
July 20, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Washington · 1

  • University of Washington · Seattle, WA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.